#25. Randal J. Kirk Buys $30.2M of INTREXON CORP latest buy: 08/13/2013
During the last six months, Kirk bet big on XON:
Randal J. Kirk
Chief Executive Officer
Intrexon is in the field of synthetic biology, an emerging and evolving discipline that applies engineering principles to biological systems. Using Co.'s suite of proprietary and complementary technologies, Co. designs, builds and regulates gene programs, which are DNA sequences that consist of key genetic components. A single gene program or a complex, multi-genic program is fabricated and stored within a DNA vector. Vectors are segments of DNA used as a vehicle to transmit genetic information. DNA vectors can, in turn, be introduced into cells in order to generate a simple or complex cellular system, which are the basic and complex cellular activities that take place within a cell.
XON — Key Stats (updated 17 hours, 32 minutes ago)
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.